Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Stem Cell Study for Long COVID-19 Neurological Symptoms
Phase 1
Not yet recruiting
- Conditions
- Post-Acute COVID-19 Syndrome
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Charles Cox
- Target Recruit Count
- 12
- Registration Number
- NCT06156241
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
ACT for CP Individual Patient Expanded Access IND Protocol
- Conditions
- Cerebral Palsy
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Charles Cox
- Registration Number
- NCT03203941
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury
Phase 1
Withdrawn
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2010-12-01
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- Charles Cox
- Registration Number
- NCT01251003
- Locations
- 🇺🇸
The University of Texas Medical School at Houston, Children's Memorial Hermann Hospital, Houston, Texas, United States
News
No news found